| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/09/1993 | WO1993000921A1 Remedy for osteoporosis |
| 01/09/1993 | CA2090453A1 Remedy for osteoporosis |
| 01/09/1993 | CA2068694A1 Determination of dna sequences of a novel group of major grass pollen allergens and the synthesis of their corresponding recombinant proteins |
| 01/09/1993 | CA2046484A1 Peptides |
| 01/07/1993 | WO1993000443A1 Purification of recombinant apolipoprotein e from bacteria |
| 01/07/1993 | WO1993000441A1 Hormone-secreting cells maintained in long-term culture |
| 01/07/1993 | WO1993000436A1 Papillomavirus l2 protein |
| 01/07/1993 | WO1993000433A1 A differentiated megakaryocyte line producing novel megakaryocyte differentiation factors |
| 01/07/1993 | WO1993000432A1 Bmp-9 compositions |
| 01/07/1993 | WO1993000431A1 Ctl4a receptor, fusion proteins containing it and uses thereof |
| 01/07/1993 | WO1993000427A2 Neurite growth regulatory factors |
| 01/07/1993 | WO1993000425A1 A novel receptor-type tyrosine kinase and use thereof |
| 01/07/1993 | WO1993000366A1 Method for treating immunological disorders and diseases |
| 01/07/1993 | WO1993000362A1 New peptides (didemnins), their preparation and their use |
| 01/07/1993 | WO1993000357A1 Therapeutic polypeptides based on von willebrand factor |
| 01/07/1993 | WO1993000111A1 Monoclonal antibody to lymphocyte-associated cell surface protein |
| 01/07/1993 | WO1993000110A1 Method of stimulating immune response |
| 01/07/1993 | WO1993000109A1 Method of stimulating immune response using growth hormone |
| 01/07/1993 | WO1993000108A1 Novel inhibitors of platelet aggregation |
| 01/07/1993 | WO1993000107A1 Therapeutic fragments of von willebrand factor |
| 01/07/1993 | WO1993000105A1 Calpain-inhibiting peptide analogs of the kininogen heavy chain |
| 01/07/1993 | WO1993000103A1 Chimeric envelope proteins for viral targeting |
| 01/07/1993 | WO1993000102A1 Apc polypeptides and anti-peptide antibodies, diagnostic methods and systems for inhibitng apc, and therapeutic methods |
| 01/07/1993 | WO1993000092A1 Improved process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates |
| 01/07/1993 | WO1993000079A1 Method of preventing and treating chemotherapy-induced alopecia |
| 01/07/1993 | WO1993000077A1 Orally administrable therapeutic proteins and method of making |
| 01/07/1993 | WO1993000071A1 Dosage form for a delayed drug delivery |
| 01/07/1993 | WO1993000052A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 01/07/1993 | WO1993000051A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 01/07/1993 | WO1993000050A1 Pharmaceutical formulations of osteogenic proteins |
| 01/07/1993 | WO1993000049A1 Osteogenic factor |
| 01/07/1993 | EP0521842A2 Tumor antigen specific antibody |
| 01/07/1993 | EP0521827A1 Pharmacological active hydrazin derivatives and process for their preparation |
| 01/07/1993 | EP0521586A1 FSH and other recombinant hormones |
| 01/07/1993 | EP0521408A1 Glycopeptide antibiotics derivated from balhimycin |
| 01/07/1993 | EP0521388A1 Process for the preparation of a pharmaceutical preparation containing at least two different actives and use thereof |
| 01/07/1993 | EP0521240A2 Novel bacteriocin from lactococcus lactis subspecies lactis |
| 01/07/1993 | EP0520983A1 Calcitonin suppository formulations |
| 01/07/1993 | EP0390849B1 Methyl cellulose pharmaceutical composition |
| 01/07/1993 | DE4122402A1 Verwendung von interleukin 10 zur herstellung von arzneimitteln mit tumorhemmender wirksamkeit Use of interleukin 10 for the manufacture of medicaments having tumor-inhibiting efficacy |
| 01/07/1993 | DE4121947A1 2-(3-(4-amidino-phenyl))-propionsaeurederivate, ihre herstellung und verwendung 2- (3- (4-amidino-phenyl)) - propionic acid derivatives, their preparation and use |
| 01/07/1993 | DE4121662A1 New balhimycin derivs. obtd. from Actinomyces Y-86,21022 |
| 01/07/1993 | CA2580812A1 Ctla4 receptor, fusion proteins containing it and uses thereof |
| 01/07/1993 | CA2112496A1 Method of preventing and treating chemotherapy-induced alopecia |
| 01/07/1993 | CA2112492A1 A differentiated megakaryocyte line producing novel megakaryocyte differentiation factors |
| 01/07/1993 | CA2112376A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 01/07/1993 | CA2112375A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 01/07/1993 | CA2112112A1 Hormone-secreting cells maintained in long-term culture |
| 01/07/1993 | CA2111870A1 Calpain-inhibiting peptide analogs of the kininogen heavy chain |
| 01/07/1993 | CA2109705A1 Method of stimulating immune response |
| 01/07/1993 | CA2093790A1 Osteogenic factor |
| 01/06/1993 | CN1067678A Recombinant b oligomer of pertussis toxin |
| 01/05/1993 | US5177208 Orthomolecular method of treating sickle cell disease |
| 01/05/1993 | US5177197 Isolated nucleotide sequence expressing human transforming growth factor-β1-binding protein |
| 01/05/1993 | US5177194 Process for purifying immune serum globulins |
| 01/05/1993 | US5177193 In vivo half-life, genetic engineering |
| 01/05/1993 | US5177189 Polypeptide analogs of Apolipoprotein E |
| 01/05/1993 | US5177065 Fructose or ribose, starch hydrolyzate, film-forming agent |
| 01/05/1993 | US5177061 Method for stimulating hair growth using GHL-Cu complexes |
| 01/05/1993 | US5177060 Anti-inflammatory peptides and treatment to inhibit vascular leakage in injured tissues |
| 01/05/1993 | US5177058 Insulin derivatives |
| 01/05/1993 | US5177017 Molecular cloning of the genes responsible for collagenase production from Clostridium histolyticum |
| 01/05/1993 | US5177002 Glycosidases |
| 01/05/1993 | US5177001 In vitro enzymatic conversion of glycosylated mammalian vitamin D-binding protein to a potent macrophage activating factor |
| 01/05/1993 | US5177000 Monoclonal antibodies selective for prostate cancer and diagnostic immunoassay for prostate cancer |
| 01/05/1993 | US5176996 Method for making synthetic oligonucleotides which bind specifically to target sites on duplex DNA molecules, by forming a colinear triplex, the synthetic oligonucleotides and methods of use |
| 01/05/1993 | US5176994 Immunoassay |
| 01/05/1993 | US5176912 Injections of Desensil" solution |
| 01/05/1993 | US5176635 Twin-chamber syringe filled with a charge of activity-sensitive human protein as active substance |
| 01/05/1993 | CA1312278C Process for the preparation of factor viii:c-deficient plasma, and a deficient plasma obtained in this way |
| 01/03/1993 | WO1993001166A1 4-amino-3-hydroxycarboxylic acid derivatives |
| 01/03/1993 | CA2109326A1 4-amino-3-hydroxycarboxylic acid derivatives |
| 01/02/1993 | WO1993000925A1 Isolation and characterization of a novel protease from streptomyces lividans |
| 01/02/1993 | CA2090463A1 Isolation and characterization of a novel protease from streptomyces lividans |
| 01/02/1993 | CA2072834A1 Ketone derivatives |
| 01/02/1993 | CA2072824A1 Cluster conjugates of drugs with antibodies |
| 01/02/1993 | CA2072533A1 Process for the preparation of a pharmaceutical formulation containing at least two different active substances and use of such a formulation |
| 01/02/1993 | CA2072395A1 Bicyclic endothelin analogues |
| 01/02/1993 | CA2072390A1 Endothelin analogues with alpha-amine substitution at residue 20 |
| 12/30/1992 | EP0520843A2 The acid sphingomyelinase gene and diagnosis of niemann-pick disease |
| 12/30/1992 | EP0520834A2 Pharmaceutical composition for treating an immune system disorder comprising PP14 or antibodies against PP14 |
| 12/30/1992 | EP0520823A2 Non-substrate peptide inhibitors of farnesyl protein transferase |
| 12/30/1992 | EP0520748A1 Storage of materials |
| 12/30/1992 | EP0520573A1 Cyclic imide derivatives |
| 12/30/1992 | EP0520499A1 Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane |
| 12/30/1992 | EP0520427A1 Cyclopropenone derivatives |
| 12/30/1992 | EP0520237A2 Bone replacement material containing fibroblast growth factors |
| 12/30/1992 | EP0520158A1 Truncated forms of the hepatocyte growth factor (HGF) receptor |
| 12/30/1992 | EP0520029A1 Methods and compositions for the treatment of malignancies in which a protein kinase is associated. |
| 12/30/1992 | EP0519986A1 Synthetic polypeptides |
| 12/30/1992 | EP0208785B1 Fibrinophilic urokinase complex and process for its preparation |
| 12/30/1992 | EP0124613B1 Novel plasminogen activator derived from human kidneys, process for its preparation, and thrombolytic drug containing the same |
| 12/30/1992 | CN1067431A Amidinophenylalanine derivatives, process for their preparation, their use and compositions containing them |
| 12/30/1992 | CA2072725A1 Glycopeptides, a process for their preparation and their use |
| 12/29/1992 | WO1993001286A2 Localized oligonucleotide therapy |
| 12/29/1992 | WO1993000439A1 In vivo delivery of active factors by co-cultured cell implants |
| 12/29/1992 | US5175272 DNA sequences with increased expression of HBcAg |
| 12/29/1992 | US5175257 Useful for delivering radioisotopes to desired target sites in vivo |
| 12/29/1992 | US5175253 Serpin-enzyme complex receptor binding pentapetides |
| 12/29/1992 | US5175252 Cloned gene encoding for bacteriocin from pediococcus acidilactici |